324 related articles for article (PubMed ID: 29102432)
1. Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.
Grani G; Lamartina L; Durante C; Filetti S; Cooper DS
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):500-514. PubMed ID: 29102432
[TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
Xu B; Ghossein R
Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated carcinoma of the thyroid.
Boone RT; Fan CY; Hanna EY
Otolaryngol Clin North Am; 2003 Feb; 36(1):73-90, viii. PubMed ID: 12803010
[TBL] [Abstract][Full Text] [Related]
5. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
[TBL] [Abstract][Full Text] [Related]
6. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
Renshaw AA; Gould EW
Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
[TBL] [Abstract][Full Text] [Related]
7. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
8. Current approaches to the treatment of well-differentiated thyroid cancer.
Angelos P
Oncology (Williston Park); 2002 Mar; 16(3):309-15; discussion 315, 318, 323-4. PubMed ID: 15046390
[TBL] [Abstract][Full Text] [Related]
9. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
Haigh PI; Urbach DR
Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
[TBL] [Abstract][Full Text] [Related]
10. Hurthle cell neoplasm of the thyroid gland.
Sidhu S
ANZ J Surg; 2008 Mar; 78(3):115. PubMed ID: 18269467
[No Abstract] [Full Text] [Related]
11. Follicular and Hürthle cell lesions of the thyroid: can inconclusive results be minimized?
Sherman JF; Leiman G; Naud S; Nathan MH; Ambaye AB
Acta Cytol; 2008; 52(6):659-64. PubMed ID: 19068668
[TBL] [Abstract][Full Text] [Related]
12. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003.
Mills SC; Haq M; Smellie WJ; Harmer C
Eur J Surg Oncol; 2009 Mar; 35(3):230-4. PubMed ID: 18722077
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of accordance between cytological and histopathological findings in selected thyroid tumors].
Gołkowski F; Jabrocka A; Huszno B; Trofimiuk M; Buziak-Bereza M; Kulig J; Cichoń S
Przegl Lek; 2004; 61(1):10-2. PubMed ID: 15230098
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
16. Report of a hürthle cell neoplasm in a peripubertal girl.
Bremer AA; Feldman BJ; Iezza G; Clark OH; Rosenthal SM
Thyroid; 2007 Feb; 17(2):175-8. PubMed ID: 17316121
[TBL] [Abstract][Full Text] [Related]
17. Contemporary management of thyroid cancer.
Blankenship DR; Chin E; Terris DJ
Am J Otolaryngol; 2005; 26(4):249-60. PubMed ID: 15991091
[TBL] [Abstract][Full Text] [Related]
18. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
19. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
20. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]